MedsFacts.com




MedsFacts Meta-Analysis covering adverse side effect reports of CRESTOR patients who developed OCCIPITAL NEURALGIA.


Introduction: MedsFacts provides MD-approved analysis to help both patients and physicians accurately research and assess the risk-reward trade off for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration, social media, and MedsFacts user submissions. Between January 2004 and October 2012, 19 individuals taking CRESTOR reported OCCIPITAL NEURALGIA to the FDA. A total of 57104 CRESTOR drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

Topics covered: This page is designed to help you determine the relationship, if any, between CRESTOR and OCCIPITAL NEURALGIA. In doing so, we compare CRESTOR with other drugs that cause OCCIPITAL NEURALGIA, to help you evaluate whether or not CRESTOR causes OCCIPITAL NEURALGIA. Likewise, this page shows the most highly-reported side effects of CRESTOR, so you can see if OCCIPITAL NEURALGIA ranks among CRESTOR's most well-known side effects.

The Dashboard explained: The Dashboard first shows general Summary Statistics for CRESTOR and OCCIPITAL NEURALGIA, such as the raw number and percentage of patients in FDA reports who used CRESTOR and developed OCCIPITAL NEURALGIA. Next, the Dashboard lists the most common reasons (indications) why CRESTOR was prescribed for patients. We then display a pie-chart which shows, in aggregate, what we believe represents general physician opinion of the safety of CRESTOR. This pie-chart summarizes, for all FDA reports covering CRESTOR, whether or not the treating physician felt CRESTOR (versus other drugs the patient was taking) was responsible for the adverse side-effects. After the pie-chart, we itemize the most common side effects in FDA studies covering CRESTOR. You may click on any of these side effects to learn more about them, in general, or specifically for CRESTOR. Finally, we identify the drugs most widely associated with CRESTOR in FDA literature. You may also click on any of these drugs to view it's dashboard.

Dashboard view of our research literature concerning CRESTOR :

Summary Statistics
Reports of CRESTOR causing OCCIPITAL NEURALGIA: 19
Reports of any side effect of CRESTOR : 57104
Percentage of CRESTOR patients where OCCIPITAL NEURALGIA is a reported side effect: 0.033272625385262%

FDA reports of any drug causing OCCIPITAL NEURALGIA : 117
Average percentage for all medicated patients where OCCIPITAL NEURALGIA is reported as a complication: 0.00073328693361027%
Most frequent diagnoses/indications for prescribing CRESTOR:
BLOOD CHOLESTEROL INCREASED ( 8450 patients )
HYPERCHOLESTEROLAEMIA ( 4097 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 2846 patients )
HYPERLIPIDAEMIA ( 1945 patients )
BLOOD CHOLESTEROL ( 1358 patients )
DRUG USE FOR UNKNOWN INDICATION ( 1035 patients )
DYSLIPIDAEMIA ( 935 patients )
BLOOD CHOLESTEROL ABNORMAL ( 398 patients )
BLOOD TRIGLYCERIDES INCREASED ( 240 patients )
LOW DENSITY LIPOPROTEIN INCREASED ( 183 patients )
Physician opinion on CRESTOR as adverse event culprit:

(* global)
Twitter feed for CRESTOR - Pending/Beta





Basic reports are available, free of charge, in PDF format and are suitable for scientific publication. Further data and analytics are available upon request. We are in the process of adding new features to our site, including Q&A interface for patients to speak with experts on medication. Check back with us again in the near future to see.





Copyright 2013 MedsFacts
info@medsfacts.com
Privacy Policy
Terms of use